Does Combined Treatment with Tranexamic Acid and Vancomycin Affect Human Chondrocytes In Vitro?
Authors:
- Mike WagenbrennerMWMike Wagenbrenner
- Tizian HeinzTHTizian Heinz
- Philip M. AndersonPAPhilip M. Anderson
- Ioannis StratosIoannis Stratos
- Joerg ArnholdtJAJoerg Arnholdt
- Susanne Mayer-WagnerSusanne Mayer-Wagner
- Konstantin HorasKHKonstantin Horas
- Denitsa DochevaDenitsa Docheva
- Boris M. HolzapfelBoris M. Holzapfel
- Maximilian RudertMaximilian Rudert
- Manuel WeißenbergerMWManuel Weißenberger
Open Access
- 24 November 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (12) , 1576
Abstract
Background: The aim of our study was to examine the combined effects of tranexamic acid (TXA) and vancomycin powder (VP) on chondrocytes in vitro. Despite the use of TXA and VP being linked to a reduced risk of extensive postoperative blood loss and periprosthetic joint infections (PJIs) in TKA, the possible cytotoxic side effects on periarticular cell types remain unclear. Methods: Human chondrocytes were harvested from hyaline cartilage and expanded in monolayer culture before being simultaneously exposed to different concentrations of TXA and VP for varying exposure times. Cell viability and proliferation were assessed using an ATP assay and an Annexin 5 assay, respectively, while changes in the relative expression of chondrogenic marker genes were examined using semiquantitative RT-PCR. Results: The simultaneous exposure of chondrocytes to TXA and VP for more than 48 h led to a reduction in both cell viability and proliferation rates. When exposing chondrocytes to the lowest examined concentrations of both TXA (10 mg/mL) and VP (3 mg/mL), the observed effects were delayed until 96 h. However, our study found no dependencies of the observed effects on the concentrations tested. Further, we found no effects on the expression of chondrogenic marker genes. Conclusions: Consequently, limiting the exposure time of chondrocytes to TXA and VP in an in vitro setting to 24 h may be considered safe and could help to further improve the understanding of the safe use of substances in vivo. However, further in vitro research is required to develop a comprehensive understanding of the effects of both VP and TXA on important periarticular cell types in TKA, including chondrocytes, osteocytes, and tenocytes.Keywords
Funding Information
- Open Access Publication Fund of the University of Wuerzburg
This publication has 40 references indexed in Scilit:
- Effect of various admixtures on selected mechanical properties of medium viscosity bone cements: Part 3 – Glassy carbonComposite Structures, 2024
- Chondrotoxic effects of tranexamic acid and povidone-iodine on the articular cartilage of rabbitsInternational Orthopaedics, 2023
- Toxicity of tranexamic acid (TXA) to intra‐articular tissue in orthopaedic surgery: a scoping reviewKnee Surgery, Sports Traumatology, Arthroscopy, 2020
- The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 yearsKnee Surgery, Sports Traumatology, Arthroscopy, 2020
- Vancomycin is toxic to human chondrocytes in vitroArchives of orthopaedic and trauma surgery, 2020
- No effect of topical application of tranexamic acid on articular cartilageKnee Surgery, Sports Traumatology, Arthroscopy, 2017
- Mesenchymal stem cells in the aseptic loosening of total joint replacementsJournal of Biomedical Materials Research Part A, 2016
- Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic reviewKnee Surgery, Sports Traumatology, Arthroscopy, 2013
- The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta‐analysisKnee Surgery, Sports Traumatology, Arthroscopy, 2011
- Altered in vitro chondrogenic properties of chondrocytes harvested from unaffected cartilage in osteoarthritic jointsOsteoarthritis and Cartilage, 2006